Clinical Trials Directory

Trials / Completed

CompletedNCT03118193

Biomarkers of Antidepressant Resistance

Biomarkers of Antidepressant Resistance - BIORESA

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
University Hospital, Tours · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

According to the WHO, major depressive disorders have become the second worldwide cause of disability. Treatment, long-term medication, leads to frequent resistance (up to 40%). Establishing a cerebral molecular signature of depression is not feasible in humans (need for cerebral samples). The alternative is to use peripheral biological samples (blood, urine, saliva). Metabolomic is the integrated and quantitative study of all the metabolites of a biological system. This aims to define the metabolic status of an organism for a particular condition. Metabolites are derived from biological extracts (cells, tissues, serum, plasma, urine, etc.) and are detected by: * liquid or gas chromatography coupled to mass spectrometry (LC-MS, GC-MS), * proton nuclear magnetic resonance (1 H-NMR). The biomarkers resulting from these studies have become important diagnostic criteria, measured objectively and evaluated as indicators of a normal or pathological state, or even predictors of treatment efficacy. This approach allows the discovery of biomarkers that best describe the status of a disease for better understanding and are usable in a context of individualized medicine, with effects on clinical practice and management.

Conditions

Interventions

TypeNameDescription
OTHERolfactive testsolfactive tests: odor identification, odor discrimination and olfactory threshold
BIOLOGICALblood testone sample of 4mL
BIOLOGICALCollection of faecesCollection of faeces by patient at home - optional
DEVICETissue Pulsatility imagingUltrasound exploration of brain pulsatility - optional

Timeline

Start date
2017-06-16
Primary completion
2021-01-12
Completion
2021-01-12
First posted
2017-04-18
Last updated
2025-12-23

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03118193. Inclusion in this directory is not an endorsement.